The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010.

作者: C. Musumba , A. Jorgensen , L. Sutton , D. Eker , J. Moorcroft

DOI: 10.1111/J.1365-2036.2012.05118.X

关键词:

摘要: Summary Background Recent data from Western countries indicate that the aetiology of peptic ulcer disease (PUD) is changing as prevalence Helicobacter pylori decreasing while use low-dose aspirin (LDA, ≤325 mg/day) increasing. Aim To investigate and demographics PUD in a well-characterised patient cohort at large tertiary hospital UK between July 2005 June 2010. Methods Patients diagnosed with following endoscopy were categorised non-steroidal anti-inflammatory drug (NSAID)-users or non-users, their H. status determined. Comparisons NSAID-users non-aspirin LDA-users summarised using counts corresponding percentages (for categorical variables) means standard deviations continuous variables). Results Overall, 386 patients enrolled; 57% used NSAIDs (51% LDA only) 43% non-users. whole was pylori-positive (including 66% duodenal ulcers 47% gastric ulcers). Compared older (mean age 68 vs. 61 years) fewer (52% 63%). 71 62 years) more likely to be (61% 41%) than those NSAIDs. Twelve per cent neither nor pylori-positive. Conclusions The NSAIDs, particularly LDA, most commonly associated this cohort. Our findings are compatible decline increase non-NSAID, non-H. previously reported.

参考文章(36)
Harry H‐X Xia, Nghl Phung, Jamshid S Kalantar, Nicholas J Talley, Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease. The Medical Journal of Australia. ,vol. 173, pp. 515- 519 ,(2000) , 10.5694/J.1326-5377.2000.TB139318.X
E. H. Fletcher, D. E. Johnston, C. R. Fisher, R. J. Koerner, J. L. Newton, C. S. Gray, Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin Alimentary Pharmacology & Therapeutics. ,vol. 32, pp. 831- 839 ,(2010) , 10.1111/J.1365-2036.2010.04415.X
McColl Ke, Helicobacter pylori-negative ulcer disease. Journal of Gastroenterology. ,vol. 35, pp. 47- 50 ,(2000)
J. C. Thijs, H. P. M. Festen, E. J. Kuipers, The prevalence of Helicobacter pylori in peptic ulcer disease. Alimentary Pharmacology & Therapeutics. ,vol. 9, pp. 59- 69 ,(1995)
Marcel JM Groenen, Ernst J Kuipers, Bettina E Hansen, Rob J Th Ouwendijk, None, Incidence of duodenal ulcers and gastric ulcers in a Western population: Back to where it started Canadian Journal of Gastroenterology & Hepatology. ,vol. 23, pp. 604- 608 ,(2009) , 10.1155/2009/181059
M. Michael Wolfe, David R. Lichtenstein, Gurkirpal Singh, Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. The New England Journal of Medicine. ,vol. 340, pp. 1888- 1899 ,(1999) , 10.1056/NEJM199906173402407
Gianmichele Meucci, Roberto Di Battista, Carla Abbiati, Rossella Benassi, Luigi Bierti, Aurora Bortoli, Enrico Colombo, Aldo Ferrara, Alberto Prada, Giancarlo Spinzi, Renato Venturelli, Roberto de Franchis, Prevalence and risk factors of Helicobacter pylori-negative peptic ulcer: a multicenter study. Journal of Clinical Gastroenterology. ,vol. 31, pp. 42- 47 ,(2000) , 10.1097/00004836-200007000-00010
Henry Lik-Yuen Chan, Justin Chi-Yuen Wu, Francis Ka-Leung Chan, Cheung-Lung Choi, Jessica Yuet-Ling Ching, Yuk-Tong Lee, Wai-Keung Leung, James Yun-Wong Lau, Sheung-Chee Sydney Chung, Joseph Jao-Yiu Sung, Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients. Gastrointestinal Endoscopy. ,vol. 53, pp. 438- 442 ,(2001) , 10.1067/MGE.2001.112840
J. P. GISBERT, X. CALVET, Review article: Helicobacter pylori-negative duodenal ulcer disease. Alimentary Pharmacology & Therapeutics. ,vol. 30, pp. 791- 815 ,(2009) , 10.1111/J.1365-2036.2009.04105.X
Munir Pirmohamed, Sally James, Shaun Meakin, Chris Green, Andrew K Scott, Thomas J Walley, Keith Farrar, B Kevin Park, Alasdair M Breckenridge, Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients BMJ. ,vol. 329, pp. 15- 19 ,(2004) , 10.1136/BMJ.329.7456.15